1. Home
  2. JWEL vs BIAF Comparison

JWEL vs BIAF Comparison

Compare JWEL & BIAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jowell Global Ltd.

JWEL

Jowell Global Ltd.

N/A

Current Price

$2.46

Market Cap

5.0M

ML Signal

N/A

Logo bioAffinity Technologies Inc.

BIAF

bioAffinity Technologies Inc.

SELL

Current Price

$2.10

Market Cap

4.6M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
JWEL
BIAF
Founded
2012
2014
Country
China
United States
Employees
N/A
57
Industry
Other Consumer Services
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0M
4.6M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
JWEL
BIAF
Price
$2.46
$2.10
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
8.1K
476.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$20.04
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.47
$0.16
52 Week High
$2.98
$13.50

Technical Indicators

Market Signals
Indicator
JWEL
BIAF
Relative Strength Index (RSI) 57.88 78.12
Support Level $2.02 $1.23
Resistance Level $2.98 $3.58
Average True Range (ATR) 0.11 0.17
MACD 0.02 0.07
Stochastic Oscillator 91.53 62.00

Price Performance

Historical Comparison
JWEL
BIAF

About JWEL Jowell Global Ltd.

Jowell Global Ltd is a cosmetics, health, nutritional supplements, and household products e-commerce platform in China. The company offers its branded products to customers and also sells and distributes products from other companies on its platform. In addition, it allows third parties to open their stores on its platform for a service fee based on their sales revenues generated from their online stores and provides them with information about market needs, enabling them to manage their sales effort, as well as an effective platform to promote their brands. The company currently operates under four sales channels: Online Direct Sales, Authorized Retail Store Distribution, Third-party Merchants, and Live streaming marketing. Geographically, it generates all of its revenue from the PRC.

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

Share on Social Networks: